Keywords: transdermal, adhd, patch, looks, promising, sano, corp

Transdermal ADHD Patch Looks Promising

Article | 12 June 1997

Sano Corp's once-daily transdermal patch comprising Bristol-MyersSquibb's BuSpar (buspirone) may be a safe and effective treatment alternative for children with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Buspar

Buspirone

Testosterone

transdermal

Go to drug listing